Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 23, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for RISPERDAL

« Back to Dashboard

Payment Methods and Pharmacy Types for RISPERDAL (2016)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$47,900,092
DRUG STORE	$69,345,223
[disabled in preview]	$0
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	45,708
DRUG STORE	90,865
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$69,345,223
SELF OR FAMILY	$91,316,466
[disabled in preview]	$0
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for RISPERDAL

Drug Units Sold Trends for RISPERDAL

Annual Sales Revenues and Units Sold for RISPERDAL

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or try a Free Trial
Drug Name	Revenues (USD)	Units	Year
RISPERDAL	➤ Try a Free Trial	➤ Try a Free Trial	2016
RISPERDAL	➤ Try a Free Trial	➤ Try a Free Trial	2015
RISPERDAL	➤ Try a Free Trial	➤ Try a Free Trial	2014
RISPERDAL	➤ Try a Free Trial	➤ Try a Free Trial	2013
RISPERDAL	➤ Try a Free Trial	➤ Try a Free Trial	2012
Drug Name	Revenues (USD)	Units	Year

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.